Letters

Treating major depression in children and adolescents

BMJ 2004; 328 doi: http://dx.doi.org/10.1136/bmj.328.7438.525-a (Published 26 February 2004) Cite this as: BMJ 2004;328:525

Use of selective serotonin reuptake inhibitors needs urgent clarification

  1. Andrew Herxheimer, emeritus fellow ([email protected])
  1. UK Cochrane Centre London N3 2NL

    EDITOR—Ramchandani's editorial focuses entirely on the use of selective serotonin reuptake inhibitors in the treatment of major depressive disorder, just as did the statements of the chairman of the Committee on Safety of Medicines on which he comments.1 Did he not think it odd that the statement said nothing about obsessive-compulsive …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe